Global Endocrine
Testing Market, By Test (Thyroid, Insulin, Follicle Stimulating Hormone,
Luteinizing, Hormone, Estradiol, Testosterone, Human Chorionic Gonadotropin,
Prolactin, Cortisol DHEA-S, Others) By Diagnostic Technology ( Immunoassay,
Tandem Mass Spectrometry, Monoclonal and Polyclonal antibodies, Sensors
Technologies, Clinical Chemistry , Others), By End User (Hospitals and Diagnostic
Laboratories, Others), and By Region (North America, Latin America, Europe,
Asia Pacific, Middle East, and Africa), is estimated to be valued at US$
3,403.0 million in 2020 and is expected to exhibit a CAGR of 5.3 % over the
forecast period (2020-2027), as highlighted in a new report published by
Coherent Market Insights.
Key companies are focusing on
product developments for testing of diabetes mellitus, one of the most common
endocrinal disorders, globally. For instance, in 2018, Roche Diabetes Care
India, a leading company in monitoring diabetes with their testing kits, launched
a novel self- monitoring glucometer Accu-Chek Instant S for testing of glucose
levels in blood of diabetic patients.
Moreover, companies are highly
focused on innovation and advancements in rapid testing and diagnosis of
diabetes to strengthen their market share in the global endocrine testing
market. For instance, in 2019, iQ Group Global launched an innovative
technology in saliva based glucose testing for diagnosis and testing the
glucose level in blood.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1755
Global Endocrine Testing Market –
Impact of Coronavirus (Covid-19) Pandemic
Due to the lockdown, diabetic
patients are unable to visit diagnostic laboratories due to risk of diabetic
patients getting infected by COVID-19 infections. Therefore, safety procedures
such as maintaining social distancing, proper management of blood spills while
collecting blood samples, and use of personal protection equipment must be
followed and evaluated for patients having diabetic conditions, as diabetic
patients are more prone towards the risk of COVID-19 infection..
According to Journal of
Reproductive Science report in 2020, fundamental principles such as social
distancing and use of personal protection equipment should be followed by
clinicians of diagnostics laboratories while performing testing procedures on
patients
According to Indian Society of
Assisted Reproduction report in 2020, while conducting semen analysis, it
should be ensured that the male candidate is COVID-19 negative by reverse
transcription polymerase chain reaction (RT-PCR)
Browse 45 Market Data Tables and
35 Figures spread through 200 pages and in-depth TOC on “Global Endocrine
Testing Market, By Test ( Thyroid, Insulin, Follicle Stimulating Hormone,
Luteinizing, Hormone, Estradiol, Testosterone, Human Chorionic Gonadotropin,
Prolactin, Cortisol DHEA-S, Others) By Diagnostic Technology ( Immunoassay,
Tandem Mass Spectrometry, Monoclonal and Polyclonal antibodies, Sensors
Technologies, Clinical Chemistry , Others), By End User (Hospitals and
Diagnostic Laboratories, Others), and By Region (North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa),
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/endocrine-testing-market-1755
The market is expected to gain
significant growth during the forecast period, as various companies are
focusing on research and development in the field of endocrine testing.
For instance, in 2018, MiraCare
launched TechCrunch Disrupt SF, a novel self-monitoring fertility testing
device for women who are suffering from fertility problems. TechCrunch Disrupt
SF is a personalized self-monitoring device used for cycle predication in women
by monitoring fertility hormone through urine samples in females.
Key Takeaways of the Global
Endocrine Testing Market:
The global endocrine testing
market is expected to exhibit a CAGR of 5.3 % over the forecast period, owing
to robust product pipeline, and increasing approval of new endocrine testing
devices and diagnostic procedures
Among test , insulin and thyroid
segments are estimated to hold dominant position in the endocrine testing
market in 2020, owing to rising prevalence of diabetes and thyroid related
disorders (hypothyroidism and hyperthyroidism)
Among diagnosis technology type,
sensor technologies endocrine testing market segment is estimated to hold
dominant position in the endocrine testing market in 2020, due to rise
technological advancements and increasing prevalence of endocrine related disorders
Among end user, diagnostic
laboratories market segment is estimated to hold dominant position in the
endocrine testing market in 2020, owing to rising diagnostic procedures due to
high number of individuals suffering from fertility, diabetes, and thyroid
related conditions
Key players operating in global
endocrine testing market include Abbott Laboratories, Thermo Fisher Scientific,
Bio-Rad Laboratories, Inc., Beckmann Coulter, Inc., Agilent Technologies, Inc,
Siemens Healthineers AG, BioMérieux SA, Quest Diagnostics, and F. Hoffmann-La
Roche AG.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1755
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment